aXivite boosts formula in premium sports nutrition product for body weight control

| 28 april, 2022 | 0 kommentarer

aXichem AB (publ), that develops and markets natural analogue industrial compounds, announces that its capsaicin analogue product aXivite is added to the formula of the premium product Fat Burn Acitve. Fat Burn Active is a brand of the exclusive online drugstore Nuvialab, a well known player in the idustry, and the product is produced and promoted in Europe by Bart Spólka Sp.k. (BART), aXichem’s Polish distributor.  During the past six months aXichem has announced several orders for product development from BART and aXichem expects to see more new consumer products with aXivite as an active ingredient hitting the market during 2022. The total value of BART’s orders during the beginning of 2022 amounts to approximately SEK 500,000.

“The sports nutrition segment is growing and aXivite has shown excellent characteristics when tested in formulas for new products. It is great to see that aXivite also bring additional value to already best selling products such as Fat Burn Active. aXichem has a strong competitive advantage of having a well-documented and thoroughly tested ingredient, that in low doses shows great effect on metabolism, gut health, and body fat/body weight control,” says Torsten Helsing, CEO of aXichem.

More about aXivite®

aXivite is a natural analogue product, developed to fit as a component in food supplement and nutrition products. aXivite is an adjusted version of aXichem’s synthetically produced and patented capsacin, aXiphen®. Since the product is synthetically produced the substance has a number of advantages compared to natural capsaicin. The main difference is that natural capsaicin is extracted from chili and therefore varies in quality and seldom reaches a concentration above 85 percent. aXiphen® holds a concentration of at least 97 percent and has predictable characteristics. One of the key industrial benefits with the product is that aXichem can determine its water- and fat solubility, which is critical when using the substance in various kinds of products. aXiphen has a GRAS food clearance in the U.S. and a Novel Food approval for the EU.

The global fat burn supplement market is expected to register a CAGR of about 7.0% during 2018-2023. The market is highly competitive, especially in the developed economies, like Europe and North America. Also, the market is expected to witness a strong growth in the developing economies of Asia-Pacific (www.mordorintelligence.com).

This information was published by the contact person below on 28 April 2022, 08:30 AM CET.

Torsten Helsing, CEO, aXichem, Ph+46 70 686 33 55. Email: [email protected]

aXichem’s business idea is to develop, patent and market natural analogue industrial compounds. The Company primarily works with phenyl capsaicin a structural analogue of capsaicin with a wide range of applications, such as feed additives, nutrition and supplements, marine anti-fouling products and certain pharmaceutical areas. aXichem’s shares are listed on NASDAQ First North Growth Market under AXIC A. Certified Adviser: Redeye AB [email protected] +46 (0)8 121 576 90. Read more about the company at www.axichem.se

Kategori: Marknadsnyheter

Om skribenten ()

Tanalys är en sajt för investerare som med teknisk analys vill förbättra sin trading. Tanalys erbjuder teknisk analys från flera ledande analytiker, samt nyheter och utbildningar.

Lämna ett svar

Din e-postadress kommer inte publiceras.